JOURNAL OF BUON, cilt.24, sa.4, ss.1719-1726, 2019 (SCI İndekslerine Giren Dergi)
Purpose: Tyrosine kinase inhibitors (TKIs) are frequently used drugs in oncology practice. Although oral administration is an advantage, long-term use increases potential drug-drug interaction risk. The purpose of this study was to assess the prevalence of potential TKI-drug interaction (PTDI) in patients who used TKIs and increase awareness of this subject.